Breast cancer is now a disease of epidemic proportions across civilization. It is the most common malignant cancer among women. According to estimations by the WHO, breast cancer accounts for 25.1% of all cancers in women around the world. Colorectal cancer comes second (9.2%), lung cancer third (8.8%), and cervical cancer fourth (7.9%). The number of breast cancer cases is constantly growing, and not only among women from risk groups. Data from the American Cancer Society show that eight out of nine women diagnosed with cancer had no cases of breast cancer in their family. The increased incidence of breast cancer is observed among young women who are not subject to screening, but also among those qualified for such programs. Breast cancer progression rates are unpredictable and may be very fast. This is evidenced by so-called interval cancers, i.e., cancers which occur during intervals between regular ultrasounds/mammograms.

Breast cancer incidence statistics are alarming, and thus early detection is extremely important. Regular checks are one of the most important elements in the treatment process, since they allow for the detection of changes at an early stage and quick initiation of treatment. Doctors emphasize that no diagnostic method is 100% effective and it is therefore very important to combine various methods. Numerous research institutes and doctors around the world are working on new diagnostic solutions to increase the chances of detecting cancer at an early stage. Today it is also very important that new testing methods offer high comfort for patients, to encourage women to attend examinations with increased frequency and regularity.

In response to the real need for contemporary breast cancer detection, BRASTER has created an In-Home Breast Examination System, which is a breakthrough in the use of contact thermography and telemedicine to examine the breast and detect oncological diseases at home. It complements the primary methods of breast cancer detection and is safe, painless, and does not use radiation. By offering an innovative device for reliable breast self-examination and a telemedicine service, the company adheres to its mission of fighting for a future where women of any age will be able to check the health of their breasts each month without needing to leave their homes.

The Braster Telemedical Centre, inspired by international trends in the healthcare sector, is part of the dynamic development of telemedicine, which is one of the fastest growing sectors in medicine around the world. Ageing societies, growing health awareness, and an increasing incidence of chronic diseases have resulted in a growing number of patients and a higher demand for high-quality medical services. At the same time, an increasingly active search for ways to reduce the costs of medical services and an insufficient number of appropriately qualified medical personnel have led to the development of telemedicine, which has become an integral part of the healthcare market. According to estimations presented in the BCC Research report entitled “Global Markets for Telemedicine Technologies”, the global market of telemedicine devices and services will grow on average by 18.3% annually until 2021, by which time it will be valued at USD 55.1 billion compared to USD 23.8 billion in 2016.

The chart below presents the value of the telemedicine market according to estimations by BCC Research.

Source: BCC Research, "Global Markets for Telemedicine Technologies”

The report by Market Data Forecast entitled "Global Telemedicine Market 2015–2020” points to the increasing importance of telemedicine devices and services in the process of efficient monitoring and prevention of chronic diseases, which according to estimations by the World Health Organization (WHO) will be the cause of almost 75% of deaths around the world by 2020. The authors of the “Telehealth Report”, published in January 2014 by IHS Technology, also point to a growing percentage of people suffering from chronic heart failure, chronic obstructive pulmonary disease, diabetes, hypertension, and mental disorders as recipients of telemedicine services.

The highest share in the telemedicine market belongs to the countries of North America and Europe. A significant increase in the shares of countries such as Brazil, China, Russia, and India is predicted due to the size and growth rate of their populations, as well as an increasing incidence of chronic diseases.

The strategic goal of BRASTER is to transform the Company into a global telemedicine platform, offering services aimed at early breast cancer detection, using medical devices, and integrating telemedicine solutions and devices of other producers with a global sales potential. Therefore, the development of the Company will to a large extent depend on its performance in the global telemedicine market.